These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of the thrombogenecity of microvascular prosthesis by in vivo microscopy. Kim YB; Reisch HP; Serafin D; Klitzman B J Korean Med Sci; 1994 Oct; 9(5):357-61. PubMed ID: 7702782 [TBL] [Abstract][Full Text] [Related]
3. Heparin bonding increases patency of long microvascular prostheses. Ritter EF; Fata MM; Rudner AM; Klitzman B Plast Reconstr Surg; 1998 Jan; 101(1):142-6. PubMed ID: 9427927 [TBL] [Abstract][Full Text] [Related]
4. Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. Laredo J; Xue L; Husak VA; Ellinger J; Greisler HP Am J Surg; 2003 Nov; 186(5):556-60. PubMed ID: 14599625 [TBL] [Abstract][Full Text] [Related]
5. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts. Heyligers JM; Verhagen HJ; Rotmans JI; Weeterings C; de Groot PG; Moll FL; Lisman T J Vasc Surg; 2006 Mar; 43(3):587-91. PubMed ID: 16520178 [TBL] [Abstract][Full Text] [Related]
6. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575 [TBL] [Abstract][Full Text] [Related]
7. Improvement of patency rate in heparin-coated small synthetic vascular grafts. Walpoth BH; Rogulenko R; Tikhvinskaia E; Gogolewski S; Schaffner T; Hess OM; Althaus U Circulation; 1998 Nov; 98(19 Suppl):II319-23; discussion II324. PubMed ID: 9852921 [TBL] [Abstract][Full Text] [Related]
8. Sustained Thromboresistant Bioactivity with Reduced Intimal Hyperplasia of Heparin-Bonded Polytetrafluoroethylene Propaten Graft in a Chronic Canine Femoral Artery Bypass Model. Freeman J; Chen A; Weinberg RJ; Okada T; Chen C; Lin PH Ann Vasc Surg; 2018 May; 49():295-303. PubMed ID: 29197605 [TBL] [Abstract][Full Text] [Related]
10. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model. Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716 [TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass. Lumsden AB; Morrissey NJ; J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929 [TBL] [Abstract][Full Text] [Related]
13. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results. Daenens K; Schepers S; Fourneau I; Houthoofd S; Nevelsteen A J Vasc Surg; 2009 May; 49(5):1210-6. PubMed ID: 19394550 [TBL] [Abstract][Full Text] [Related]
16. The effect of carbon coating and porosity on early patency of expanded polytetrafluoroethylene grafts: an experimental study. Akers DL; Du YH; Kempczinski RF J Vasc Surg; 1993 Jul; 18(1):10-5. PubMed ID: 8326650 [TBL] [Abstract][Full Text] [Related]
17. Platelet deposition on ePTFE grafts coated with fibrin glue with or without FGF-1 and heparin. Zarge JI; Gosselin C; Huang P; Vorp DA; Severyn DA; Greisler HP J Surg Res; 1997 Jan; 67(1):4-8. PubMed ID: 9070173 [TBL] [Abstract][Full Text] [Related]